Practice-changing melanoma and skin cancer treatments come from clinical trials.

Melanoma and Skin Cancer Trials (MASC Trials) is Australia and New Zealand’s collaborative trials group specialising in investigator-initiated melanoma and skin cancer research. Working with leading researchers and institutions locally and around the globe, MASC Trials develops, conducts, and publishes research and clinical trials that improve how we diagnose and treat melanoma and skin cancer.

0

Trials

0

Hospital
Sites

0

Countries

0

Patients
Enrolled

What We Do

MASC Trials brings together a powerful network of almost 2,000 professionals who represent the many disciplines critical to our work – oncologists, surgeons, radiation specialists, nurses, allied health professionals, health economists, statisticians, research scientists, clinical research associates, data managers, patient advocates and others.

With expert support from our Advisories and our trials staff, MASC Trials leads and designs research and clinical trial development, and provides project management for multicentre, national and international collaborations.

Collaboration drives outcomes

Recruiting trials

Active trials closed for recruitment

Active trials in start up

Completed trials

Research Studies

Melanoma and skin cancer, Australia's national cancer, doesn't discriminate.

It affects young and old, men and women, in big cities or in small towns.

Donate now and support our most promising researchers to find cures for melanoma and skin cancers and give survivors long and healthy lives.

TWITTER

LATEST NEWS

Headshot of a Melanoma and Skin Cancer Trials CEO

MASC Trials welcomes new CEO

Melanoma and Skin Cancer Trials is pleased to announce the appointment of Cheryl-Ann Hawkins as Chief Executive. With decades of experience in clinical trials, Cheryl-Ann

Read More »

OUR PARTNERS